If they have struggled with side effects with the first medication, they may benefit from a one- to two-week break before starting the new one
These results far exceed the Phase 2 trial outcomes and position retatrutide as potentially the most effective weight loss medication in development
Semaglutide delays gastric emptying, which may affect absorption of oral disease-modifying therapies such as fingolimod, teriflunomide, and dimethyl fumarate
Perhaps even more meaningful than mean weight loss is that most patients who were randomly assigned to the drug were able to achieve 10%, 15% and 20% benchmarks for weight reduction
How is GLP-1 therapy different from other weight loss options
FDA sent a warning letter to HealthPartners Neuroscience Center Research and Innovation in Saint Paul, MN for objectionable conditions following a nonclinical laboratory inspection conducted as part of FDAs Bioresearch Monitoring Program